Correlation Between Assertio Therapeutics and Sangui Biotech

Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Sangui Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Sangui Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Assertio Therapeutics and Sangui Biotech International, you can compare the effects of market volatilities on Assertio Therapeutics and Sangui Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Sangui Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Sangui Biotech.

Diversification Opportunities for Assertio Therapeutics and Sangui Biotech

0.37

Correlation Coefficient

Assertio Therapeutics  Sangui Biotech

Weak diversification

The 3 months correlation between Assertio and Sangui is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Sangui Biotech International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangui Biotech Inter and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Sangui Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangui Biotech Inter has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Sangui Biotech go up and down completely randomly.

Pair Corralation between Assertio Therapeutics and Sangui Biotech

Given the investment horizon of 90 days Assertio Therapeutics is expected to generate 0.16 times more return on investment than Sangui Biotech. However, Assertio Therapeutics is 6.27 times less risky than Sangui Biotech. It trades about -0.22 of its potential returns per unit of risk. Sangui Biotech International is currently generating about -0.21 per unit of risk. If you would invest  96.00  in Assertio Therapeutics on October 11, 2024 and sell it today you would lose (13.00) from holding Assertio Therapeutics or give up 13.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Assertio Therapeutics  vs.  Sangui Biotech International

Assertio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Assertio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Sangui Biotech Inter

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sangui Biotech International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Assertio Therapeutics and Sangui Biotech

The main advantage of trading using opposite Assertio Therapeutics and Sangui Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Sangui Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangui Biotech will offset losses from the drop in Sangui Biotech's long position.

The idea behind Assertio Therapeutics and Sangui Biotech International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..